Research programme: cancer gene/chemotherapy - Rega Institute for Medical Research
Latest Information Update: 25 Aug 2006
At a glance
- Originator Rega Institute for Medical Research
- Class
- Mechanism of Action DNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 25 Aug 2006 No development reported - Preclinical for Cancer in Belgium (unspecified route)
- 17 Sep 2002 Preclinical trials in Cancer in Belgium (unspecified route)